![Bozena Zembrzuski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bozena Zembrzuski
Fondatore presso Specialised Therapeutics Asia Pte Ltd.
Profilo
Bozena Zembrzuski is the founder of Specialised Therapeutics Asia Pte Ltd.
She held the title of Director-People & Culture since the company's founding in 2008.
Posizioni attive di Bozena Zembrzuski
Società | Posizione | Inizio |
---|---|---|
Specialised Therapeutics Asia Pte Ltd.
![]() Specialised Therapeutics Asia Pte Ltd. Medical SpecialtiesHealth Technology Specialised Therapeutics Asia Pte Ltd. is a Singaporean international biopharmaceutical company that provides healthcare solutions to patients in Southeast Asia, Australia, and New Zealand. Specialised Therapeutics Asia is based in Singapore, Singapore. The private company collaborates with leading pharmaceutical and diagnostic companies to bring innovative therapies to patients with a range of diseases. The company's therapeutic portfolio includes novel agents in oncology, haematology, neurology, ophthalmology, and supportive care. The company was founded in 2008 by Carlo Montagner and Bozena Zembrzuski, and Carlo Montagner has been the CEO since then. | Fondatore | 01/01/2008 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Specialised Therapeutics Asia Pte Ltd.
![]() Specialised Therapeutics Asia Pte Ltd. Medical SpecialtiesHealth Technology Specialised Therapeutics Asia Pte Ltd. is a Singaporean international biopharmaceutical company that provides healthcare solutions to patients in Southeast Asia, Australia, and New Zealand. Specialised Therapeutics Asia is based in Singapore, Singapore. The private company collaborates with leading pharmaceutical and diagnostic companies to bring innovative therapies to patients with a range of diseases. The company's therapeutic portfolio includes novel agents in oncology, haematology, neurology, ophthalmology, and supportive care. The company was founded in 2008 by Carlo Montagner and Bozena Zembrzuski, and Carlo Montagner has been the CEO since then. | Health Technology |
- Borsa valori
- Insiders
- Bozena Zembrzuski